Bunuel
A study of 86 patients, all of whom suffered from disease T and received the same standard medical treatment, divided the patients into 2 equal groups. One group’s members all attended weekly support group meetings, but no one from the other group attended support group meetings. After 10 years, 41 patients from each group had died. Clearly, support group meetings do not help patients with disease T live longer.
Which one of the following statements, if true, most seriously weakens the argument?
(A) Of the 4 patients who survived more than 10 years, the 2 who had attended weekly support group meetings lived longer than the 2 who had not.
(B) For many diseases, attending weekly support group meetings is part of the standard medical treatment.
(C) The members of the group that attended weekly support group meetings lived 2 years longer, on average, than the members of the other group.
(D) Some physicians have argued that attending weekly support group meetings gives patients less faith in the standard treatment for disease T.
(E) Everyone in the group whose members attended weekly support group meetings reported after 1 year that those meetings had helped them to cope with the disease.
EXPLANATION FROM Fox LSAT
This is an interesting question, because it contains two separate flaws. The first is the very common flaw of assuming that two groups in a study were randomly selected when it is possible that they were not. This issue appears
all the time on the LSAT. Here, we know that there were two equal groups. But couldn’t the doctors have given the group with worse initial conditions the support group treatment in addition to the standard medical treatment? If this is true, then the “study” really isn’t a scientific experiment and it would be very hard to reach any conclusion from the study’s results. We’re asked to find a weakener, so something like, “The patients who got the support group treatment had much worse initial diagnoses,” would be a good answer.
The second flaw this argument makes is that it assumes that ten years is the only relevant timeframe for assessing the success of a certain treatment. But that’s silly, when you consider a couple hypothetical alternatives. What if the study had said, “One hundred years later, all the members of both groups were dead, therefore there is no difference in the two treatments”? Or what if the study had said, “Ten minutes later, all the members of both groups were still alive, therefore there is no difference in the two treatments”? If the study had done either of those, then it would be obviously stupid. Imagine if the disease in question was some sort of super-nasty terminal cancer. What if the folks that got the support group treatment lived for nine years, and the folks that didn’t get the support group treatment lived nine weeks? Would it make sense to say, “Ten years later they were all pretty much dead, therefore the support group treatment had no effect”? Of course not. We’re asked to find a weakener, so something like, “The group that got the support group treatment lived much longer, on average, than the other group,” would be a good answer.
We’ve predicted not one, but two good answers. Let’s see if we can find one of them (or something similar) in the answer choices.
A) Nah. The four remaining patients is a terribly small sample. I don’t think this would be a devastating weakener, even if it were true.
B) Totally irrelevant. For disease T, one group got the support group and the other group did not. Who cares whether support group treatment is “standard” for other diseases.
C) This is very much like our second prediction, above. I love it. Note that it’s much better than A, because it’s about a much bigger sample of people.
D) Who cares what “some physicians” think. This is very weak, and we already found a strong answer in C.
E) “Coping” is nice, but it’s not relevant here. The only thing that is relevant to the conclusion of the argument that was actually made is
living longer.
Answer C, if true, shows that the support group does help patients to live longer. So C is our answer.